Latest Merck Stories
-Mitchell Seyedin, Ph.D., to serve as Executive Chairman in newly created role- ST. LOUIS, Jan. 9, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held orthobiological regenerative medicine company, announced today that George W. Dunbar, Jr., a well-recognized senior executive with over 25 years' experience in the field of life sciences, was appointed President and Chief Executive Officer, effective immediately. Mitchell Seyedin, Ph.D., will continue to serve the Company...
Revenue Growth of 12%-14% Expected Year-over-Year BOSTON, Jan. 9, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced preliminary, unaudited financial results of the fourth quarter and year ended December 31, 2013. For the fourth quarter of 2013, the Company expects to report: -- Total revenues in the range of $7.4 to $8.0 million, as compared with $7.1 million in the fourth quarter of 2012. -- Services revenues from Molecular Profiles in the...
- Remarkable; prodigious.
- Audacious; gutsy.
- Completely; extremely.
- Audaciously; boldly.
- Impressively great in size; enormous; extraordinary.